BA.2, driven to near-zero levels by BA.5, still haunt us, spawning monstrous viruses that, after vanishing for months, burst forth, gnarled & hideous, in novel antibody armor. The latest, which I found skulking around India, has 13 spike mutations. 1/28 github.com/cov-lineages/p…
There have been just 4 sequences so far, but they’ve been in Indian cities roughly 800-1300 km apart from each other. Spike mutations consist of three deletions + 10 amino acid substitutions, two of which (K478T & R493Q) are reversions. 2/28
Most of these mutations are familiar, & known for their antibody-evading properties. The most unique are the K478T reversion & R1091H, an uncommon S2 mutation. But in this thread, I want to discuss the three new deletions, all in the amino-terminal domain (NTD). 3/28
The NTD, at spike-protein amino acid (AA) sites 14-306, is possibly the most variable region in the SARS-CoV-2 genome, but the reasons for NTD mutations are usually less clear than for the receptor-binding domain (RBD, sites 331-528). 5/28
The RBD binds the ACE2 receptor on human cells & is the primary target of neutralizing antibodies, & most mutations there can be attributed to the effect they have on ACE2 affinity and/or antibody evasion. 6/28
The NTD is, to a lesser extent, also targeted by antibodies, primarily at the NTD antigenic supersite. The NTD contains five loops that extend outward, known as N1, N2, N3, N4, & N5. Loops N1, N3, & N5 largely form the NTD supersite. 7/28
At precisely what amino acid sites are these NTD loops located?
• N1 Loop—14-26
• N2 Loop—67-81
• N3 Loop—140-158
• N4 Loop—174-188
• N5 Loop—241-263 embopress.org/doi/full/10.15…
8/28
As described below, SARS-CoV-2’s NTD loops are long compared to those of other sarbecoviruses, especially N2, N3, & N5. It is precisely at these loops that we see the vast majority of NTD deletions in SARS-CoV-2. 9/28
NTD deletions, by shortening the length of these projecting loops, can help SARS-CoV-2 evade antibodies, a fact first proven by @mccarthy_kr. He showed this, impressively, before any VOC with deletions had yet emerged. 10/28 science.org/doi/10.1126/sc…
But there is more to these NTD deletions than just immune evasion. The most common deletion has been ∆69-70—found in Alpha, BA.1, BA.4/5, & others—and it plays little to no role in immune evasion. 11/28
Variations in NTD-loop length through deletions & insertions turn out to be common in other sarbecoviruses, suggesting their broad utility at facilitating evolutionary change, possibly by compensating for changes caused by mutations elsewhere. 12/28
For example, @GuptaR_lab found that ∆69-70 usually accompanied RBD mutations (like N439K &Y453F) that strengthen ACE2 binding and/or evade immunity but which also reduce viral infectivity. 13/28
∆69-70, inserted into pseudoviruses, increased infectivity & when H69/V70 residues were re-inserted back into Alpha, cell entry, S1/S2 spike cleavage (an essential step in entry), & ability to fuse cells (form syncytia) were all greatly impaired. 14/28
More generally, deletions that shorten NTD loops appear to greatly increase the ability of SARS-CoV-2 to fuse with cell membranes, infect cells, and fuse cells together. 15/28
SARS1 has much shorter NTD loops than SARS2. @EnyaQing found that replacing the SARS2 NTD with the SARS1 NTD in virus-like particles (VLP) enormously increases its ability to fuse with cell membranes and infect cells. 16/28
Similar results were found by @GroveLab when replacing SARS-CoV-2’s NTD with that of Pangolin CoV, which has very short NTD loops. 17/28
By exposing VLP’s to dissolved ACE2 receptors, one can determine the degree to which RBDs are in the exposed “up” position, which is necessary for binding ACE2. The more a VLP is inhibited from fusing w/cell-like particles by dissolved ACE2, the greater the RBD exposure. 18/28
It turns out that by this measure, SARS-CoV-1 NTD—which, again, has much shorter NTD loops than SARS-CoV-2 & is therefore a good proxy for SARS-CoV-2 viruses bearing many deletions—enhances RBD exposure. 19/28
So if shorter NTD loops improves cell entry, fusion with cell membranes, the ability to fuse cells together (syncytia formation), and RBD exposure, why don’t all SARS-CoV-2 have large deletions, shortening their NTD loops? 20/28
NTD deletions must exact a cost, & that cost is spike-protein instability. Putting the SARS2+SARS1-NTD VLP’s through a mildly stressful procedure resulted in the loss of the S1 portion of spike, destroying cell entry & fusion capability. 21/28
So NTD deletions often confer antibody-evading powers and can powerfully increase a virus’s ability to infect cells and fuse cells together, but this comes at the cost of spike instability, leaving it vulnerable to permanent inactivation. 22/28
What determines whether a given NTD deletion will be deleterious or advantageous? The environment of course, most powerfully, the spike protein background. “The impact of NTD hypervariability depends on the S protein background.” 23/28
In fact, it was only after the D614G mutation stabilized spike that NTD deletions became possible. The authors of this study—which is impossible to do justice to here—issued an ominous & prescient warning (written in May 2021, before Delta’s properties were known). 24/28
“That a genetic drift around metastable set points can potentially generate hyper-fusogenic CoVs with enhanced cell entry potential is an important consideration in understanding CoV cell entry, transmission, & pathogenicity.” Indeed. 25/28
Will this particular BA.2 monstrosity, or any of the others, turn out to be hyper-fusogenic, with Delta-like disease severity? My guess is not simply because they retain the Omicron S2, which seems to annihilate all fusogenicity. 26/28
But a reversion to greater fusogenicity, LRT tropism, & Delta-like disease severity seems extremely likely at some point. We would do well to acknowledge this & recognize the necessity of instituting serious NPIs when it happens. 27/28
As usual, I want to emphasize that I’m not an expert in these matters and have no formal credentials. It’s entirely possible I’ve misinterpreted something in this thread, and I welcome corrections and comments from all. 28/28
Finally, thank you to all the hard-working scientists throughout the world sequencing & uploading virus sequences, without which surveillance would be impossible—@r_karyakarte, for example. And thanks to @GISAID for organizing & storing these sequences so they can be monitored.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
@DameSunshine @SharonBurnabyBC B.1.1.529 wasn't/isn't a real variant; it's a placeholder that represents a putative ancestor of BA.1/BA.2/BA.3.
Bad sequences and/or coinfections tend to get categorized as B.1.1.529:—they have enough Omicron muts to be ID'd as Omicron but so much dropout/mixed signals...
1/
@DameSunshine @SharonBurnabyBC ...that a specific designation isn't possible. Travel sequencing in the US is done by Ginkgo Bioworks. Their sequences are generally poor quality & they upload *pooled* sequences—against database guidelines. The B.1.1.529 here are likely low-quality/pooled sequences from GBW.
2/
@DameSunshine @SharonBurnabyBC I think it's entirely possible that a new, divergent variant will emerge this summer. There are hints with BA.3.2 & a 50-spike-mutation BQ.1.1 that has transmitted at least once. Other similar chronic infection-derived variants are undoubtedly lurking all over, unsequenced.... 3/
Incredible how quickly @yunlong_cao & co provide us w/info on the latest emerging SARS-CoV-2 variants.
Already, we have great data on BA.3.2 (the divergent saltation lineage detected in South Africa & the Netherlands & NB.1.8.1, an emerging contender for global dominance. 1/9
BA.3.2 is a clear outlier on the antigenic cartography map—as expected given the enormous differences between its spike protein & every other circulating variant. 2/9
It's unsurprising, therefore, that BA.3.2 evades antibodies from human sera more effectively than any other variant, though the degree of its superiority is striking. 3/9 biorxiv.org/content/10.110…
About 1 month after this monster BQ.1.1 appeared, an even more extreme sequence has shown up in Alberta. Like the BQ, it has 50 private spike mutations, but it also has >40 AA mutations elsewhere in the genome. 1/6
They include the full panoply of NSP3, NSP12, & N muts I've written about previously. ORF1a:S4398L is the most common mutation in the 4395-4398 region, this has ∆S4398, a rarity also seen in a few other extremely divergent seqs w/this constellation. 2/6
In a theme that's become familiar, it's added two spike NTD glycans, N30 (via F32S) and N155 (via S155N+F157S).
Another chronic-infection leitmotif (first noted by @SolidEvidence): reversions to common or consensus residues in related Bat-CoVs, including SARS-1. 3/6
A fascinating SARS-CoV-2 sequence was recently uploaded—collected from a dog in Kazakhstan in July 2022.
Usher places the seq 1 nuc mut from the Wuhan ref seq—C21846T/S:T95I—i.e. pre-D614G. Could this seq somehow have a close connection to the first days of the pandemic?
1/19
Of the sequences near this one on the tree, all are low-quality & clearly bad BA.1 or Delta sequences. The only genuine one is from the UK, collected April 2020. So it's likely even S:T95I was not inherited.
This sequence has several fascinating aspects. 2/
(This all assumes the sequence is accurate and that C241T & C14408T (ORF1b:P314L) are genuinely absent. Its mutational characteristics make me certain this is a good sequence, though it's not impossible there's dropout not indicated hiding C241T and/or C14408T.) 3/
Do you remember BA.3—the weakling cousin of BA.1 & BA.2 that seemed to take the worst from each & had weaker ACE2 binding than even the ancestral Wuhan Virus?
After 3 years, BA.3 is back.
And it is transmitting.
Who saw this coming?
1/13
While the full extent of the new BA.3’s spread is not known, it’s been detected in 2 different South African regions through regular (not targeted) surveillance by @Dikeled61970012, @Tuliodna, & the invaluable South African virology community.
2/13 github.com/cov-lineages/p…
After nearly 3 years of intrahost evolution in a chronically infected person, the new BA.3 is almost unrecognizable. It has ~41 spike AA substitutions (4 of which are 2-nuc muts) to go with 14 AA deletions (∆136-147+∆243-244). We’ve seen nothing like this since 2023.
3/13